タイトル
検索に戻る
検索結果

結果:22件
(1から20までを表示します.)

次の検索結果へ→


アンコールセッション1
ALK・KRAS
座長:木浦 勝行(岡山大学病院呼吸器・アレルギー内科)
Benjamin J. Solomon1・Todd Bauer2・Enriqueta Felip3・Geoffrey Liu4・Julien Mazieres5・Filippo de Marinis6・*Yasushi Goto7・Dong-Wan Kim8・Konstantin Laktionov9・Fiona Blackhall10・Elisa Dall'O11・Anna Polli11・Francesca Toffalorio11・Tony Mok12
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia1;Sarah Cannon Research Institute Tennessee Oncology, Nashville, TN, USA2;Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain3;Princess Margaret Cancer Centre, Toronto, Canada4;Toulouse University Hospital, Toulouse, France5;European Institute of Oncology IRCCS, Milan, Italy6;National Cancer Center Hospital, Tokyo, Japan7;Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea8;Federal State Budgetary Institution “N.N.Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation(N.N. Blokhin NMRCO), Moscow, Russia9;University of Manchester, Manchester, UK10;Pfizer, Milan, Italy11;State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Hong Kong12
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション1
ALK・KRAS
座長:木浦 勝行(岡山大学病院呼吸器・アレルギー内科)
Benjamin J. Solomon1・Todd Bauer2・Tony Mok3・Geoffrey Liu4・Julien Mazieres5・Filippo de Marinis6・*Yasushi Goto7・Dong-Wan Kim8・Yi-Long Wu9・Mikhail Dvorkin10・Jacek Jassem11・Froylán López-López12・Ross Soo13・Anna Polli14・Elisa Dall'O14・Laura Iadeluca15・Francesca Toffalorio14・Enriqueta Felip16
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia1;Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN, USA2;State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Hong Kong3;Princess Margaret Cancer Centre, Toronto, Canada4;Toulouse University Hospital, Toulouse, France5;European Institute of Oncology IRCCS, Milan, Italy6;National Cancer Center Hospital, Tokyo, Japan7;Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea8;Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China9;Budget Healthcare Institution of Omsk Region, Omsk, Russian Federation10;Medical University of Gdańsk, Gdańsk, Poland11;San Peregrino Cancer Center, Aguascalientes, Mexico12;National University Cancer Institute, Singapore, Singapore13;Pfizer, Milan, Italy14;Pfizer Inc., New York, NY, USA15;Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain16
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション1
ALK・KRAS
座長:木浦 勝行(岡山大学病院呼吸器・アレルギー内科)
*Takayasu Kurata1・Bob T. Li2・Vamsidhar Velcheti3・Timothy J. Price4・David S. Hong5・Marwan G. Fakih6・Dong-Wan Kim7・Gerald Falchook8・Jean Pierre Delord9・Grace Dy10・Suresh S. Ramalingam11・John Strickler12・Jurgen Wolf13・Adrian Sacher14・Alfredo Addeo15・Hans Prenen16・Antreas Hindoyan17・Abraham Anderson17・Agnes Ang17・Ferdinandos Skoulidis5
Department of Thoracic Oncology, Kansai Medical University Hospital1;Memorial Sloan Kettering CA Center2;New York University3;Queen Elizabeth Hospital4;MD Anderson CA Center5;City of Hope Comprehensive CA Center6;Seoul National University7;Sarah Cannon Research Institute8;Institut Claudius Regaud9;Roswell Park Comprehensive CA Center10;Winship CA Institute11;Duke University12;Universitatsklinikum Koln13;Princess Margaret CA Centre14;University Hospital of Geneva15;University Hospitals Leuven16;Amgen17
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション1
ALK・KRAS
座長:木浦 勝行(岡山大学病院呼吸器・アレルギー内科)
*Toshiaki Takahashi1・Grace K. Dy2・Ramaswamy Govindan3・Vamsidhar Velcheti4・Gerald S. Falchook5・Antoine Italiano6・Juergen Wolf7・Adrian G. Sacher8・Suresh S. Ramalingam9・Christophe Dooms10・Dong-Wan Kim11・Alfred Addeo12・Jayesh Desai13・Martin Schuler14・Pascale Tomasini15・Qui Tran16・Simon Jones16・Agnes Ang16・Abraham Anderson16・Antreas A. Hindoyan16・David S. Hong17・Bob T. Li18
Division of Thoracic Oncology, Shizuoka Cancer Center1;Roswell Park Comprehensive CA Center2;Washington University3;New York University4;Sarah Cannon Research Institute5;Institut Bergonie6;Universitatsklinikum Koln7;Princess Margaret CA Centre8;Winship Cancer Institute9;Universitair Ziekenhuis Leuven10;Seoul National University11;Hopitaux Universitaires de Geneve12;Peter MacCallum CA Centre13;Universitätsklinikum Essen14;Hopital de la Timone15;Amgen16;MD Anderson CA Center17;Memorial Sloan Kettering CA Center18
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション1
ALK・KRAS
座長:木浦 勝行(岡山大学病院呼吸器・アレルギー内科)
*Noboru Yamamoto1・On behalf of KontRASt-01 investigators2
Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan1;Other2
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション2
抗体薬物複合体
座長:大江裕一郎(国立がん研究センター中央病院呼吸器内科)
*Yasushi Goto1・Bob T. Li2・Egbert F. Smit3・Kazuhiko Nakagawa4・Koichi Goto5・Julien Mazieres6・Dipesh Uprety7・Lyudmila Bazhenova8・Andreas N. Saltos9・Enriqueta Felip10・Jose M. Pacheco11・Maurice Perol12・Luis Paz-Ares Rodrigues13・Kapil Saxena14・Ryota Shiga14・Yingkai Cheng14・Qi Yan14・David Planchard15・Pasi A. Jänne16
National Cancer Center Hospital, Tokyo, Japan1;Memorial Sloan Kettering Cancer Center, New York, NY, USA2;Netherlands Cancer Institute, Amsterdam, Netherlands3;Kindai University Hospital, Osaka, Japan4;National Cancer Center Hospital East, Chiba, Japan5;Hôpital Larrey(Centre Hospitalier Universitaire), Toulouse, France6;Karmanos Cancer Institute, Detroit, MI, USA7;UC San Diego Moores Cancer Center, San Diego, CA, USA8;Moffitt Cancer Center, Tampa, FL, USA9;Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain10;University of Colorado, Aurora, CO, USA11;Centre Léon Bérard, Lyon, France12;Hospital Universitario 12 de Octubre, Madrid, Spain13;Daiichi Sankyo, Inc., Basking Ridge, NJ, USA14;Gustave Roussy, Villejuif, France15;Dana-Farber Cancer Institute and Belfer Center for Applied Cancer Science, Boston, MA, USA16
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション2
抗体薬物複合体
座長:大江裕一郎(国立がん研究センター中央病院呼吸器内科)
*Koichi Goto1・Bob T. Li2・Myung-Ju Ahn3・Julien Mazieres4・Sukhmani K. Padda5・William Nassib William Jr6・Yi-Long Wu7・Simon Dearden8・Alejandra Ragone9・Natasha Viglianti8・Amaya Gascó Hernández10
National Cancer Center Hospital East, Kashiwa, Japan1;Memorial Sloan Kettering Cancer Center, New York, NY, USA2;Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea3;Hôpital Larrey, Service de Pneumologie, Toulouse, France4;Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA5;Hospital BP, a Beneficencia Portuguesa de São Paulo, São Paulo, Brazil6;Guangdong Provincial People's Hospital, Guangzhou, Guangdong7;AstraZeneca Pharmaceuticals, Cambridge, UK8;AstraZeneca Pharmaceuticals, Mississauga, ON, Canada9;AstraZeneca Pharmaceuticals, Gaithersburg, MD, USA10
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション2
抗体薬物複合体
座長:大江裕一郎(国立がん研究センター中央病院呼吸器内科)
*Isamu Okamoto1・Benjamin Levy2・Martin Reck3・James C. Yang4・Federico Cappuzzo5・Siddhartha Rawat6・Jingdong Xie6・Priyanka Basak6・Enriqueta Felip7
Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan1;The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA2;Lung Clinic Grosshansdorf, Airway Research Center North(ARCN), Grosshansdorf, Germany3;Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan4;Istituto Nazionale Tumori “Regina Elena”, Rome, Italy5;Daiichi Sankyo, Inc, Basking Ridge, NJ, USA6;Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona7
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション2
抗体薬物複合体
座長:大江裕一郎(国立がん研究センター中央病院呼吸器内科)
*Makoto Nishio1・Tony Mok2・Yi-Long Wu3・Martin Reck4・Elaine Wu5・David Sternberg5・Stephen Esker5・Helena Yu6
The Cancer Institute Hospital of JFCR, Tokyo, Japan1;State Key Laboratory of Translational Oncology and Chinese University of Hong Kong, Hong Kong, Hong Kong PRC2;Lung Cancer Institute, Guangdong Province People's Hospital, Guangzhou, China3;LungenClinic Grosshandorf, Grosshansdorf, Germany4;Daiichi Sankyo, Inc., Basking Ridge, NJ, USA5;Memorial Sloan Kettering Cancer Center, New York, NY, USA6
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション2
抗体薬物複合体
座長:大江裕一郎(国立がん研究センター中央病院呼吸器内科)
*Hidetoshi Hayashi1・Conor E. Steuer2・Wu-Chou Su3・Makoto Nishio4・Melissa L. Johnson5・Dong-Wan Kim6・Marianna Koczywas7・Enriqueta Felip8・Kathryn A. Gold9・Haruyasu Murakami10・Christina S. Baik11・Sang-We Kim12・Egbert F. Smit13・Mark Gigantone14・Ben Kim14・Pang-Dian Fan14・Zhenhao Qi14・Elaine Y. Wu14・David Sternberg14・Pasi A. Jänne15
Kindai University, Osaka, Japan1;Winship Cancer Institute of Emory University, Atlanta, GA, USA2;National Cheng Kung University Hospital, Tainan, Taiwan3;The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan4;Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN, USA5;Seoul National University Hospital, Seoul, South Korea6;City of Hope, Duarte, CA, USA7;Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain8;Moores Cancer Center at UC San Diego Health, San Diego, CA, USA9;Shizuoka Cancer Center, Shizuoka, Japan10;University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA11;Asan Medical Center, Seoul, South Korea12;Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands13;Daiichi Sankyo, Inc., Basking Ridge, NJ, USA14;Dana-Farber Cancer Institute, Boston, MA, USA15
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション2
抗体薬物複合体
座長:大江裕一郎(国立がん研究センター中央病院呼吸器内科)
*Kazuhiko Nakagawa1・Egbert F. Smit2・Enriqueta Felip3・Dipesh Uprety4・Luis Paz-Ares Rodrigues5・Jose M. Pacheco6・Bob T. Li7・David Planchard8・Christina Baik9・Yasushi Goto10・Haruyasu Murakami11・Andreas Saltos12・Kapil Saxena13・Ryota Shiga13・Yingkai Cheng13・Qi Yan13・Wenqin Feng13・Pasi A. Jänne14
Kindai University Faculty of Medicine, Osaka, Japan1;Netherlands Cancer Institute, Amsterdam, Netherlands2;Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain3;Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA4;Clinica Universidad de Navarra, University de Navarra, Navarra, Spain5;University of Colorado Anschutz, Aurora, CO, USA6;Memorial Sloan Kettering Cancer Center, New York, NY, USA7;Gustave Roussy, Thoracic Team, Villejuif, France8;University of Washington, Seattle, WA, USA9;National Cancer Center Hospital, Tokyo, Japan10;Shizuoka Cancer Center, Shizuoka, Japan11;Moffitt Cancer Center, Tampa, FL, USA12;Daiichi Sankyo, Inc., Basking Ridge, NJ, USA13;Dana-Farber Cancer Institute and Belfer Center for Applied Cancer Science, Boston, MA, USA14
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション2
抗体薬物複合体
座長:大江裕一郎(国立がん研究センター中央病院呼吸器内科)
*Koichi Goto1・Sang-We Kim2・Toshio Kubo3・Yasushi Goto4・Myung-Ju Ahn5・David Planchard6・Dong-Wan Kim7・James Chih-Hsin Yang8・Tsung-Ying Yang9・Kaline Pereira10・Kapil Saxena10・Ryota Shiga10・Yingkai Cheng10・Mehreteab Aregay10・Pasi A. Jänne11
Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan1;Asan Medical Center, Seoul, Republic of Korea2;Okayama University Hospital, Okayama, Japan3;National Cancer Center Hospital, Tokyo, Japan4;Samsung Medical Center, Seoul, Republic of Korea5;Gustave Roussy, Villejuif, France6;Seoul National University Hospital, Seoul, Republic of Korea7;National Taiwan University Hospital, Taipei, Taiwan8;Taichung Veterans General Hospital, Taichung, Taiwan9;Daiichi Sankyo, Inc., Basking Ridge, NJ, USA10;Dana-Farber Cancer Institute, Boston, MA, USA11
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション3
免疫療法・周術期
座長:久保田 馨(日本医科大学呼吸ケアクリニック)
*白石 祥理・谷口 友理・下川 恒生・滝口 裕一・三角 俊裕・岡本  勇・川嶋 庸介・古屋 直樹・原田 敏之・田中 寿志・小山 建一・高崎 俊和・中原 善朗・時任 高章・寺西 周平・横山 俊彦・佐藤 悠城・本田  健・岡本 浩明
胸部腫瘍臨床研究機構(TORG)
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション3
免疫療法・周術期
座長:久保田 馨(日本医科大学呼吸ケアクリニック)
*Naoyuki Nogami1・Delvys Rodríguez-Abreu2・Yi-Long Wu3・Michael Boyer4・Marina C. Garassino5・Tony S. K. Mok6・Ying Cheng7・Rina Hui8・Dariusz M. Kowalski9・Andrew G. Robinson10・Julie R. Brahmer11・Ticiana A. Leal12・Gilberto Lopes13・Byoung Chul Cho14・Silvia Novello15・Nir Peled16・Gilberto de Castro Jr17・Melanie A. Leiby18・Diana Chirovsky18・Jianxin Lin18・M. Catherine Pietanza18
National Hospital Organization Shikoku Cancer Center, Department of Thoracic Oncology, Matsuyama, Japan1;Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain2;Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China3;Chris O'Brien Lifehouse, Camperdown, NSW, Australia4;University of Chicago, IL, USA5;State Key Laboratory of Translation Oncology, Chinese University of Hong Kong, Hong Kong, China6;Department of Oncology, Jilin Cancer Hospital, Changchun, People's Republic of China7;Westmead Hospital and University of Sydney, Sydney, NSW, Australia8;Maria Sklodowska-Curie National Research Institute of Oncology, Department of Lung Cancer and Chest Tumours, Warsaw, Poland9;Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, ON, Canada10;Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA11;Carbone Cancer Center, University of Wisconsin, Madison, WI, USA;Department of Hematology & Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA(current affiliation)12;Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL, USA13;Yonsei Cancer Center, Seoul, South Korea14;Department of Oncology, AOU San Luigi Orbassano, University of Turin, Orbassano, Italy15;Shaare Zedek Medical Center, Jerusalem, Israel16;Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil17;Merck & Co., Inc., Rahway, NJ, USA18
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション3
免疫療法・周術期
座長:久保田 馨(日本医科大学呼吸ケアクリニック)
*Heather A. Wakelee1・Nasser Altorki2・Enriqueta Felip3・Eric Vallieres4・Ihor O. Vynnychenko5・Andrey Akopov6・Alex Martinez-Marti3・Antonio Chella7・Igor Bondarenko8・*Shunichi Sugawara9・Yun Fan10・Hirotsugu Kenmotsu11・Yuh-Min Chen12・Yu Deng13・Meilin Huang13・Virginia McNally14・Elizabeth Bennett13・Barbara J. Gitlitz13・Caicun Zhou15
Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA1;New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA2;Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology(VHIO), Barcelona, Spain3;Swedish Cancer Institute, Seattle, WA, USA4;Regional Municipal Institution Sumy Regional Clinical Oncology Dispensary, Sumy State University, Sumy, Ukraine5;Pavlov State Medical University, Saint Petersburg, Russia6;Pneumology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy7;Dnipro State Medical University, Dnipro, Ukraine8;Sendai Kousei Hospital, Miyagi, Japan9;Zhejiang Cancer Hospital, Hanzhou, China10;Shizuoka Cancer Center, Shizuoka, Japan11;Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taipei, Taiwan12;Genentech Inc, South San Francisco, CA, USA13;Roche Products Ltd, Welwyn Garden City, GB14;Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China15
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション3
免疫療法・周術期
座長:久保田 馨(日本医科大学呼吸ケアクリニック)
*Masahiro Tsuboi1・Yi-Long Wu2・Christian Grohe3・Thomas John4・Margarita Majem5・Jie Wang6・Terufumi Kato7・Jonathan W. Goldman8・Sang-We Kim9・Chong-Jen Yu10・Huu Vinh Vu11・Guzel Mukhametshina12・Charuwan Akewanlop13・Filippo de Marinis14・Frances A. Shepherd15・Damien Urban16・Marta Stachowiak17・Ana Bolanos18・Xiangning Huang19・Roy S. Herbst20
Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Japan1;Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China2;Klinik für Pneumologie - Evangelische Lungenklinik Berlin Buch, Berlin, Germany3;Department of Medical Oncology, Austin Health, Melbourne, Australia4;Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain5;Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China6;Department of Thoracic Oncology, Kanagawa Cancer Center, Asahi Ward, Yokohama, Japan7;David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA8;Department of Oncology, Asan Medical Center, Seoul, South Korea9;Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan10;Department Thoracic Surgery, Cho Ray Hospital, Ho Chi Minh City, Vietnam11;Republican Clinical Oncology Center, Kazan, Republic of Tatarstan, Russia12;Division of Medical Oncology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand13;Thoracic Oncology Division, European Institute of Oncology(IEO), IRCCS, Milan, Italy14;Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Canada15;Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel16;Late Oncology Research and Development, AstraZeneca, Warsaw, Poland17;Oncology Research and Development, AstraZeneca, Mississauga, Canada18;Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom19;Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA20
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション3
免疫療法・周術期
座長:久保田 馨(日本医科大学呼吸ケアクリニック)
*Yasuhiro Tsutani1・Jonathan W. Goldman2・Sanja Dacic3・Yasushi Yatabe4・Margarita Majem5・Xiangning Huang6・Allen Chen7・Toon van der Gronde7・Jie He8
Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan1;David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA2;Department of Pathology, Yale School of Medicine, New Haven, CT, USA3;Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan4;Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain5;Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom6;Late Oncology Research and Development, AstraZeneca, New York, NY, USA7;Thoracic Surgery Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China8
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション4
EGFR
座長:小林 国彦(埼玉医科大学リサーチアドミニストレーションセンター)
*高   遼1・中村  敦2・齋藤 良太3・東  公一4・守田  亮5・前門戸 任6・大泉 聡史7・高橋 和久1・各務  博8・礒部  威9・清家 正博10・菊地 利明11・岡本  勇12・森田 智視13・朝比奈 肇14・田中謙太郎12・杉尾 賢二15・小林 国彦8
順天堂大学1;仙台厚生病院2;東北大学3;久留米大学4;秋田厚生医療センター5;岩手医科大学6;北海道がんセンター7;埼玉医科大学8;島根大学9;日本医科大学10;新潟大学11;九州大学12;京都大学13;北海道大学14;大分大学15
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション4
EGFR
座長:小林 国彦(埼玉医科大学リサーチアドミニストレーションセンター)
*Isamu Okamoto1・Ryan Hartmaier2・Aleksandra Markovets2・Byoung Chul Cho3・Adrianus Johannes De Langen4・Sarah B. Goldberg5・Jonathan Goldman6・Xiuning Le7・Jonathan W. Riess8・Jan Cosaert9・Helena Yu10・Zofia Piotrowska11
Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan1;Translational Medicine, Oncology Research and Development, AstraZeneca, Boston, MA, USA2;Division of Medical Oncology, Yonsei Cancer Center, Seoul, Republic of Korea3;Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands4;Yale School of Medicine, New Haven, CT, USA5;David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA6;Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA7;Internal Medicine Haematology/Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA8;AstraZeneca Oncology Research and Development, Research and Early Development, Cambridge, UK9;Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA10;Department of Medicine, Massachusetts General Hospital, Boston, MA, USA11
第63回日本肺癌学会学術集会 2022年12月開催

アンコールセッション4
EGFR
座長:小林 国彦(埼玉医科大学リサーチアドミニストレーションセンター)
*桐田 圭輔1・釼持 広知2・坂井 和子2・盛  啓太2・加藤 晃史2・菅原 俊一2・米嶋 康臣2・東  公一2・中川 和彦2・山本 信之2・西尾 和人2・高橋 利明2
国立がん研究センター東病院1;西日本がん研究機構2
第63回日本肺癌学会学術集会 2022年12月開催

ページの先頭へ